InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,176.80
(
0.68%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.12
(
1.03%
)
Bitcoin
64,820.24
(
0.84%
)
Post# of 251599
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jaybird249

Send PM Follow Ignore
Followers 82
Posts 2822
Boards Moderated 0
Alias Born 05/05/2006

jaybird249

Re: None

Wednesday, 05/27/2015 10:00:28 PM

Wednesday, May 27, 2015 10:00:28 PM

Post# of 251599
SPHS $1.08 + $.20 has room to run
Prostate cancer is treatable with surgery but unfortunately leaves many side effects because the treatment targets the entire prostate, and can cause incontinence and impotence.

SPHS has a HUGE potential market because it targets ONLY the cancerous area within the prostate, avoiding the side effects.

IMO a $50 million market cap ($3.50 per share) is still DIRT CHEAP for the potential market for this stock.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up